Studies have shown that the expression of PI3K/Akt was significantly increased in patients with multiple CKD, alleviating renal inflammatory damage, apoptosis, and epithelial-mesenchymal transitions by inhibiting the PI3K/AKT signaling pathway [37–43]. Here, AKT1 is linked to chronic kidney disease.